AVLAYAH
Active substance: tividenofusp alfa
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TIVIDENOFUSP ALFA 150 mg/5mL
United StatesActive
Marketing holder: Denali Therapeutics Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- TIVIDENOFUSP ALFA · 150 mg/5mL
Registration
- Registration number
- 84976-001
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 84976-001 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 84976-001 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 84976-001 · Verified 2026-10-09 · open in source